Get 20% lifetime commission for referring investors to digrin.com
here.
Zentalis Pharmaceuticals, Inc. ( ZNTL) - Key Metrics
ZNTL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.10 | -$1 | -$1 |
| 2026Q1 | $0 | -$0.50 | -$0.47 | -$0.47 |
| 2025Q4 | $0 | -$0.49 | -$0.43 | -$0.43 |
| 2025Q3 | $0 | -$0.37 | -$0.37 | -$0.37 |
| 2025Q2 | $0 | -$0.37 | -$0.48 | -$0.48 |
ZNTL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.10 |
| 2026Q1 | 0% | -1.17 |
| 2025Q4 | 0% | -0.69 |
| 2025Q3 | 0% | -1.02 |
| 2025Q2 | 0% | -0.78 |
ZNTL
Price: $2.13
52 week price:
Earnings Per Share: -1.94 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 349136
Market Capitalization: 190.8 million